Synergy CHC Corp. Files S-1 Registration

TL;DR

Synergy CHC Corp. just filed an S-1, looks like they're going public or raising capital.

AI Summary

Synergy CHC Corp. filed an S-1 registration statement on August 15, 2025, for an unspecified offering. The company, formerly known as Synergy Strips Corp. and Oro Capital Corporation, Inc., is incorporated in Nevada and operates in the medicinal chemicals & botanical products sector. Its principal executive office is located at 865 Spring Street, Westbrook, ME 04092.

Why It Matters

This S-1 filing indicates Synergy CHC Corp. is preparing to offer securities to the public, which could lead to significant changes in its capital structure and market presence.

Risk Assessment

Risk Level: medium — As an S-1 filing, it signifies a company preparing for a public offering, which inherently carries market and execution risks.

Key Numbers

• 333-289645 — SEC File Number (Identifies the specific SEC registration)
• 2833 — SIC Code (Indicates industry classification (Medicinal Chemicals & Botanical Products))

Key Players & Entities

• Synergy CHC Corp. (company) — Registrant
• August 15, 2025 (date) — Filing date
• Synergy Strips Corp. (company) — Former company name
• Oro Capital Corporation, Inc. (company) — Former company name
• Nevada (jurisdiction) — State of incorporation
• 865 Spring Street Westbrook, ME 04092 (address) — Principal executive office
• Jack Ross (person) — Chief Executive Officer

FAQ

Key Financial Figures

• $0.00001 — 0 shares of our common stock, par value $0.00001 per share. The assumed public offerin
• $6.0 — y 2015 for cash consideration of $6.0 million, including earnout. In N
• $7.0 — AUD 10.0 million (approximately $7.0 million), using a mix of cash an
• $34.8 — year ended December 31, 2024 was $34.8 million, a decrease of $8&#x00a0
• $8 — was $34.8 million, a decrease of $8 million, or 19%, compared to net
• $42.8 — year ended December 31, 2023 of $42.8 million. Net revenue for the six
• $16.3 m — the six months ended June 30, 2025 was $16.3 million, a decrease of $1.1 million, or 6
• $1.1 m — , 2025 was $16.3 million, a decrease of $1.1 million, or 6% compared to net revenue of
• $17.4 million — llion, or 6% compared to net revenue of $17.4 million for the six months ended June 30, 2024.
• $14.8 million — CUSfactor net revenue decreased 5% from $14.8 million for the six months ended June 30, 2024
• $14.0 million — r the six months ended June 30, 2024 to $14.0 million for the six months ended June 30, 2025.
• $30.8 — year ended December 31, 2024 was $30.8 million, a 17.0% decrease under
• $37.2 — year ended December 31, 2023 of $37.2 million. Following the completi
• $2.1 — e and EBITDA were $34.8 million, $2.1 million and $6.5 million,
• $6.5 — #x00a0;million, $2.1 million and $6.5 million, respectively, as compar

Filing Documents

• ea0240711-03.htm (S-1) — 927KB
• ea024071103ex1-1_synergy.htm (EX-1.1) — 208KB
• ea024071103ex4-1_synergy.htm (EX-4.1) — 100KB
• ea024071103ex5-1_synergy.htm (EX-5.1) — 11KB
• ea024071103ex21-1_synergy.htm (EX-21.1) — 2KB
• ea024071103ex23-1_synergy.htm (EX-23.1) — 2KB
• ea024071103ex-fee_synergy.htm (EX-FILING FEES) — 19KB
• ex5-1_001.jpg (GRAPHIC) — 7KB
• tsynergy_001.jpg (GRAPHIC) — 75KB
• timage_001.jpg (GRAPHIC) — 1179KB
• timage_002.jpg (GRAPHIC) — 919KB
• tpiechart_001.jpg (GRAPHIC) — 161KB
• 0001213900-25-077458.txt ( ) — 4623KB
• ea024071103ex-fee_synergy_htm.xml (XML) — 8KB

RISK FACTORS

RISK FACTORS   11

USE OF PROCEEDS

USE OF PROCEEDS   14 CAPITALIZATION   15

DILUTION

DILUTION   16

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK   18 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF OUR COMMON STOCK   22

UNDERWRITING

UNDERWRITING   25 SELLING RESTRICTIONS   29 LEGAL MATTERS   31 EXPERTS   31 WHERE YOU CAN FIND MORE INFORMATION   31 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE   32 i Table of Contents ABOUT THIS PROSPECTUS You should carefully read this prospectus before deciding to invest in our securities. Neither we nor the underwriters have authorized anyone to provide you with additional information or information different from that contained in this prospectus filed with the Securities and Exchange Commission (the “SEC”), the information incorporated by reference into this prospectus and any free -writing prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The underwriters are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. The information contained in this prospectus, or any document incorporated by reference in this prospectus, is accurate only as of the date of those respective documents, regardless of the time of delivery of this prospectus or any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside the United States (“U.S.”): We and the underwriters have not done anything that would permit this offering or the possession or distribution of this prospectus in any jurisdiction where action for those purposes is required, other than in the U.S. Persons outside the U.S. who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securities and the distribution of this prospectus outside of the U.S. Trademarks We own or have rights to various trademarks, service marks and trade names that we use in connection with the operation

View Full Filing

View this S-1 filing on SEC EDGAR